14994-25-3

Basic information

• Product Name: [2-[(8R,9S,10R,13S,14S,16S,17R)-16-bromo-17-hydroxy-10,13-dimethyl-3-o xo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-y l]-2-oxo-ethyl] acetate
• Synonyms: [2-[(8R,9S,10R,13S,14S,16S,17R)-16-bromo-17-hydroxy-10,13-dimethyl-3-o xo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-y l]-2-oxo-ethyl] acetate
• CAS NO: 14994-25-3
• Molecular Formula: C23H31BrO5
• Molecular Weight: 467.39324
• Mol File: 14994-25-3.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 576.4°Cat760mmHg
• Flash Point: 302.4°C
• Appearance: /
• Density: 1.39g/cm³
• Vapor Pressure: 1.1E-15mmHg at 25°C
• Refractive Index: 1.578
• CAS DataBase Reference: [2-[(8R,9S,10R,13S,14S,16S,17R)-16-bromo-17-hydroxy-10,13-dimethyl-3-o xo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-y l]-2-oxo-ethyl] acetate(CAS DataBase Reference)
• NIST Chemistry Reference: [2-[(8R,9S,10R,13S,14S,16S,17R)-16-bromo-17-hydroxy-10,13-dimethyl-3-o xo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-y l]-2-oxo-ethyl] acetate(14994-25-3)
• EPA Substance Registry System: [2-[(8R,9S,10R,13S,14S,16S,17R)-16-bromo-17-hydroxy-10,13-dimethyl-3-o xo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-y l]-2-oxo-ethyl] acetate(14994-25-3)

Safety Data

• Hazardous Substances Data: 14994-25-3(Hazardous Substances Data)

Usage

Description

[2-[(8R,9S,10R,13S,14S,16S,17R)-16-bromo-17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate is a complex steroid derivative featuring a cyclopenta[a]phenanthrene core, an acetate functional group, a bromine atom, and a hydroxy group attached to the cyclopenta[a]phenanthrene ring. Its potential pharmacological properties warrant further research to elucidate its biological activity and possible applications.

Uses

Used in Pharmaceutical Industry:
[2-[(8R,9S,10R,13S,14S,16S,17R)-16-bromo-17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate is used as a potential pharmaceutical compound for its possible pharmacological properties. [2-[(8R,9S,10R,13S,14S,16S,17R)-16-bromo-17-hydroxy-10,13-dimethyl-3-o xo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-y l]-2-oxo-ethyl] acetate's unique structure and functional groups may contribute to its potential as a therapeutic agent, pending further research and development.
Used in Chemical Research:
In the field of chemical research, [2-[(8R,9S,10R,13S,14S,16S,17R)-16-bromo-17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate serves as a subject for studying the synthesis, structural analysis, and potential reactivity of complex steroidal derivatives. Understanding its properties can contribute to the advancement of organic chemistry and the development of new compounds with specific applications.
Please note that the provided materials do not specify any direct applications for the compound. The uses listed above are inferred based on the compound's characteristics and potential relevance in the pharmaceutical and chemical research industries. Further research would be necessary to confirm these applications and identify others.

InChI:InChI=1/C23H31BrO5/c1-13(25)29-12-20(27)23(28)19(24)11-18-16-5-4-14-10-15(26)6-8-21(14,2)17(16)7-9-22(18,23)3/h10,16-19,28H,4-9,11-12H2,1-3H3/t16-,17+,18+,19+,21+,22+,23+/m1/s1